 Ellen Elias
Concepts (262)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Smith-Lemli-Opitz Syndrome | 16 | 2025 | 17 | 2.180 |
Why?
| | Cholesterol | 16 | 2025 | 404 | 1.370 |
Why?
| | Neurodevelopmental Disorders | 4 | 2026 | 223 | 0.940 |
Why?
| | Health Services Needs and Demand | 3 | 2017 | 276 | 0.560 |
Why?
| | Nuclear Proteins | 2 | 2020 | 741 | 0.530 |
Why?
| | Transitional Care | 1 | 2017 | 45 | 0.490 |
Why?
| | Phenotype | 7 | 2026 | 3147 | 0.480 |
Why?
| | Carrier Proteins | 1 | 2019 | 733 | 0.440 |
Why?
| | Dehydrocholesterols | 8 | 2025 | 8 | 0.440 |
Why?
| | Developmental Disabilities | 4 | 2021 | 279 | 0.440 |
Why?
| | Quality Assurance, Health Care | 1 | 2017 | 341 | 0.430 |
Why?
| | Autism Spectrum Disorder | 5 | 2021 | 410 | 0.430 |
Why?
| | Mutation | 6 | 2024 | 4081 | 0.430 |
Why?
| | Abnormalities, Multiple | 12 | 2018 | 197 | 0.420 |
Why?
| | Oxidoreductases Acting on CH-CH Group Donors | 7 | 2017 | 27 | 0.390 |
Why?
| | Home Care Services, Hospital-Based | 1 | 2012 | 9 | 0.360 |
Why?
| | Equipment and Supplies | 1 | 2012 | 35 | 0.360 |
Why?
| | Self-Help Devices | 1 | 2012 | 24 | 0.360 |
Why?
| | Facies | 4 | 2020 | 22 | 0.350 |
Why?
| | Interdisciplinary Communication | 2 | 2014 | 200 | 0.350 |
Why?
| | Health Services Accessibility | 2 | 2017 | 1098 | 0.330 |
Why?
| | Cooperative Behavior | 2 | 2014 | 464 | 0.310 |
Why?
| | Child | 36 | 2026 | 22599 | 0.310 |
Why?
| | Child, Preschool | 29 | 2026 | 11789 | 0.300 |
Why?
| | Autistic Disorder | 2 | 2010 | 211 | 0.300 |
Why?
| | Megalencephaly | 2 | 2024 | 19 | 0.290 |
Why?
| | Craniofacial Abnormalities | 2 | 2019 | 78 | 0.290 |
Why?
| | Craniosynostoses | 2 | 2026 | 69 | 0.280 |
Why?
| | Psychosexual Development | 1 | 2006 | 3 | 0.250 |
Why?
| | Sexuality | 1 | 2006 | 32 | 0.240 |
Why?
| | Limb Deformities, Congenital | 2 | 2024 | 22 | 0.240 |
Why?
| | Infant | 24 | 2024 | 10022 | 0.230 |
Why?
| | Chronic Disease | 1 | 2012 | 1810 | 0.230 |
Why?
| | Intellectual Disability | 4 | 2020 | 174 | 0.230 |
Why?
| | Oxidoreductases | 6 | 2000 | 95 | 0.220 |
Why?
| | Acro-Osteolysis | 1 | 2024 | 2 | 0.220 |
Why?
| | Genetic Association Studies | 3 | 2026 | 369 | 0.210 |
Why?
| | Progeria | 1 | 2024 | 6 | 0.210 |
Why?
| | Transcription Factors | 2 | 2026 | 1726 | 0.210 |
Why?
| | RNA, Small Nuclear | 1 | 2024 | 40 | 0.210 |
Why?
| | Adolescent | 25 | 2024 | 22405 | 0.200 |
Why?
| | Retinal Rod Photoreceptor Cells | 1 | 2003 | 17 | 0.200 |
Why?
| | Vision, Ocular | 1 | 2003 | 47 | 0.200 |
Why?
| | Dwarfism | 1 | 2023 | 15 | 0.200 |
Why?
| | Osteochondrodysplasias | 1 | 2023 | 20 | 0.190 |
Why?
| | Infant, Newborn | 15 | 2018 | 6399 | 0.190 |
Why?
| | Retinal Diseases | 1 | 2003 | 101 | 0.190 |
Why?
| | Face | 4 | 2020 | 174 | 0.190 |
Why?
| | Syndrome | 10 | 2024 | 379 | 0.180 |
Why?
| | Humans | 50 | 2026 | 144665 | 0.180 |
Why?
| | Retinoblastoma-Binding Protein 2 | 1 | 2020 | 4 | 0.170 |
Why?
| | Heterozygote | 4 | 2026 | 313 | 0.160 |
Why?
| | Sexual Health | 1 | 2021 | 66 | 0.160 |
Why?
| | Mutation, Missense | 2 | 2020 | 338 | 0.140 |
Why?
| | Female | 39 | 2026 | 78301 | 0.140 |
Why?
| | Cerebellum | 1 | 1999 | 224 | 0.130 |
Why?
| | Electroretinography | 2 | 2010 | 50 | 0.130 |
Why?
| | Repressor Proteins | 1 | 2020 | 428 | 0.120 |
Why?
| | Imaging, Three-Dimensional | 1 | 2020 | 581 | 0.120 |
Why?
| | Premature Birth | 1 | 2020 | 376 | 0.120 |
Why?
| | Growth Disorders | 4 | 2023 | 86 | 0.120 |
Why?
| | Male | 27 | 2026 | 72425 | 0.120 |
Why?
| | Metabolism, Inborn Errors | 1 | 1995 | 42 | 0.110 |
Why?
| | Communication Barriers | 1 | 2017 | 130 | 0.110 |
Why?
| | Heart Defects, Congenital | 3 | 1999 | 905 | 0.110 |
Why?
| | Child Nutrition Disorders | 1 | 2014 | 20 | 0.110 |
Why?
| | Brain | 3 | 2024 | 2933 | 0.110 |
Why?
| | Puberty, Precocious | 1 | 1994 | 12 | 0.100 |
Why?
| | Genetic Predisposition to Disease | 2 | 2020 | 2350 | 0.100 |
Why?
| | Malnutrition | 1 | 2014 | 86 | 0.100 |
Why?
| | Child Abuse, Sexual | 2 | 2021 | 81 | 0.100 |
Why?
| | Meningomyelocele | 1 | 1994 | 62 | 0.100 |
Why?
| | Contraception Behavior | 2 | 2021 | 108 | 0.100 |
Why?
| | Enteral Nutrition | 1 | 2014 | 217 | 0.090 |
Why?
| | Cognition | 2 | 2020 | 1263 | 0.090 |
Why?
| | Physician's Role | 2 | 2021 | 221 | 0.090 |
Why?
| | Blood Chemical Analysis | 1 | 2012 | 109 | 0.090 |
Why?
| | Patient Protection and Affordable Care Act | 1 | 2012 | 103 | 0.090 |
Why?
| | DNA-Binding Proteins | 1 | 2018 | 1484 | 0.080 |
Why?
| | Cognitive Dysfunction | 1 | 2017 | 464 | 0.080 |
Why?
| | Hamartoma Syndrome, Multiple | 1 | 2010 | 16 | 0.080 |
Why?
| | Retinal Cone Photoreceptor Cells | 1 | 2010 | 20 | 0.080 |
Why?
| | Down Syndrome | 1 | 2016 | 522 | 0.080 |
Why?
| | PTEN Phosphohydrolase | 1 | 2010 | 164 | 0.070 |
Why?
| | Neurocutaneous Syndromes | 1 | 2009 | 3 | 0.070 |
Why?
| | Angelman Syndrome | 1 | 2009 | 11 | 0.070 |
Why?
| | Rett Syndrome | 1 | 2009 | 41 | 0.070 |
Why?
| | Bile Acids and Salts | 4 | 1997 | 163 | 0.070 |
Why?
| | Fetal Alcohol Spectrum Disorders | 1 | 2009 | 70 | 0.070 |
Why?
| | Fragile X Syndrome | 1 | 2009 | 119 | 0.070 |
Why?
| | Exons | 2 | 2026 | 362 | 0.060 |
Why?
| | Patient-Centered Care | 1 | 2012 | 545 | 0.060 |
Why?
| | Chromosome Deletion | 2 | 1997 | 124 | 0.060 |
Why?
| | Thyroid Neoplasms | 1 | 2010 | 349 | 0.060 |
Why?
| | Patient Readmission | 1 | 2012 | 765 | 0.060 |
Why?
| | Sex Education | 1 | 2006 | 34 | 0.060 |
Why?
| | Internship and Residency | 1 | 2017 | 1262 | 0.060 |
Why?
| | Beckwith-Wiedemann Syndrome | 2 | 1999 | 7 | 0.060 |
Why?
| | Child, Exceptional | 1 | 2005 | 2 | 0.060 |
Why?
| | Aortic Stenosis, Subvalvular | 1 | 2005 | 4 | 0.060 |
Why?
| | Patient Discharge | 1 | 2012 | 985 | 0.060 |
Why?
| | Pregnancy | 5 | 2021 | 7122 | 0.050 |
Why?
| | Marfan Syndrome | 1 | 2005 | 46 | 0.050 |
Why?
| | Pedigree | 1 | 2026 | 515 | 0.050 |
Why?
| | Lipid Metabolism, Inborn Errors | 2 | 1995 | 20 | 0.050 |
Why?
| | Outpatient Clinics, Hospital | 1 | 2005 | 80 | 0.050 |
Why?
| | Adult | 13 | 2018 | 40486 | 0.050 |
Why?
| | Tetralogy of Fallot | 1 | 2005 | 76 | 0.050 |
Why?
| | RNA Splice Sites | 1 | 2024 | 52 | 0.050 |
Why?
| | Self Concept | 1 | 2006 | 256 | 0.050 |
Why?
| | Spliceosomes | 1 | 2024 | 54 | 0.050 |
Why?
| | Agenesis of Corpus Callosum | 1 | 2003 | 13 | 0.050 |
Why?
| | Alleles | 2 | 2024 | 886 | 0.050 |
Why?
| | Glypicans | 1 | 2023 | 11 | 0.050 |
Why?
| | Sterols | 4 | 1997 | 20 | 0.050 |
Why?
| | Rare Diseases | 1 | 2024 | 115 | 0.050 |
Why?
| | Parent-Child Relations | 1 | 2006 | 271 | 0.050 |
Why?
| | Interpersonal Relations | 1 | 2006 | 399 | 0.050 |
Why?
| | Follow-Up Studies | 4 | 2005 | 5414 | 0.050 |
Why?
| | Siblings | 1 | 2023 | 195 | 0.050 |
Why?
| | Genetic Variation | 2 | 2018 | 985 | 0.050 |
Why?
| | Hand Deformities, Congenital | 2 | 2018 | 10 | 0.040 |
Why?
| | Hedgehog Proteins | 1 | 2023 | 197 | 0.040 |
Why?
| | Cholestadienols | 2 | 1998 | 2 | 0.040 |
Why?
| | Menstruation | 1 | 2021 | 40 | 0.040 |
Why?
| | Magnetic Resonance Spectroscopy | 1 | 2003 | 625 | 0.040 |
Why?
| | Young Adult | 4 | 2024 | 14119 | 0.040 |
Why?
| | Genetic Counseling | 1 | 2021 | 81 | 0.040 |
Why?
| | Genetic Techniques | 1 | 2020 | 67 | 0.040 |
Why?
| | Kinetics | 1 | 2003 | 1603 | 0.040 |
Why?
| | Puberty | 1 | 2021 | 135 | 0.040 |
Why?
| | Dandy-Walker Syndrome | 1 | 1999 | 7 | 0.040 |
Why?
| | Pediatricians | 1 | 2021 | 121 | 0.040 |
Why?
| | Cholesterol, Dietary | 2 | 1997 | 15 | 0.040 |
Why?
| | Spinal Dysraphism | 1 | 2021 | 110 | 0.040 |
Why?
| | Growth Hormone | 1 | 1999 | 91 | 0.040 |
Why?
| | Sexually Transmitted Diseases | 1 | 2021 | 163 | 0.040 |
Why?
| | Gene Expression Regulation, Developmental | 1 | 2024 | 906 | 0.040 |
Why?
| | Penetrance | 1 | 2018 | 30 | 0.040 |
Why?
| | Skull | 1 | 2020 | 161 | 0.040 |
Why?
| | Micrognathism | 1 | 2018 | 19 | 0.040 |
Why?
| | Amniocentesis | 1 | 1998 | 20 | 0.040 |
Why?
| | Larynx | 1 | 1999 | 56 | 0.040 |
Why?
| | Chromosome Breakage | 1 | 1998 | 23 | 0.040 |
Why?
| | Fanconi Anemia | 1 | 1998 | 11 | 0.040 |
Why?
| | Homozygote | 2 | 1995 | 200 | 0.030 |
Why?
| | Patient Transfer | 1 | 2021 | 208 | 0.030 |
Why?
| | Neck | 1 | 2018 | 108 | 0.030 |
Why?
| | Chromosomal Proteins, Non-Histone | 1 | 2018 | 129 | 0.030 |
Why?
| | Pediatrics | 1 | 2006 | 1121 | 0.030 |
Why?
| | Amniotic Fluid | 1 | 1998 | 79 | 0.030 |
Why?
| | Chromosomes, Human, Pair 22 | 1 | 1997 | 46 | 0.030 |
Why?
| | Hirschsprung Disease | 1 | 1999 | 91 | 0.030 |
Why?
| | Exome | 1 | 2018 | 227 | 0.030 |
Why?
| | Spinal Cord Injuries | 1 | 2021 | 240 | 0.030 |
Why?
| | Caregivers | 1 | 2006 | 1062 | 0.030 |
Why?
| | Intelligence Tests | 1 | 2017 | 55 | 0.030 |
Why?
| | Endocrine Glands | 1 | 1997 | 14 | 0.030 |
Why?
| | Sexual Behavior | 1 | 2021 | 493 | 0.030 |
Why?
| | Growth | 1 | 1997 | 49 | 0.030 |
Why?
| | Behavior | 1 | 1997 | 90 | 0.030 |
Why?
| | Piperazines | 2 | 1997 | 378 | 0.030 |
Why?
| | Fetal Death | 1 | 1996 | 58 | 0.030 |
Why?
| | Microcephaly | 2 | 1994 | 104 | 0.030 |
Why?
| | Chromosomes, Human, Pair 15 | 1 | 1996 | 50 | 0.030 |
Why?
| | Genotype | 2 | 2017 | 1847 | 0.030 |
Why?
| | Enzyme Inhibitors | 2 | 1997 | 820 | 0.030 |
Why?
| | Chromosomes, Human, Pair 21 | 1 | 1995 | 42 | 0.030 |
Why?
| | Microsomes, Liver | 1 | 1995 | 85 | 0.030 |
Why?
| | Mosaicism | 1 | 1996 | 73 | 0.030 |
Why?
| | Skin Diseases | 1 | 1997 | 151 | 0.030 |
Why?
| | Trisomy | 1 | 1996 | 78 | 0.030 |
Why?
| | Bone and Bones | 1 | 1997 | 317 | 0.030 |
Why?
| | Gastrointestinal Diseases | 1 | 1997 | 217 | 0.030 |
Why?
| | Kidney Diseases | 1 | 1999 | 427 | 0.030 |
Why?
| | Nutritional Requirements | 1 | 2014 | 77 | 0.030 |
Why?
| | Primary Health Care | 1 | 2005 | 1730 | 0.030 |
Why?
| | Cataract | 1 | 1997 | 212 | 0.030 |
Why?
| | United States | 1 | 2012 | 16018 | 0.030 |
Why?
| | Child Development | 1 | 2019 | 482 | 0.030 |
Why?
| | Anticholesteremic Agents | 1 | 1995 | 154 | 0.030 |
Why?
| | Menarche | 1 | 1994 | 52 | 0.030 |
Why?
| | Radiography | 3 | 2003 | 848 | 0.020 |
Why?
| | Mice, Knockout | 1 | 2020 | 3109 | 0.020 |
Why?
| | Professional-Family Relations | 1 | 2014 | 153 | 0.020 |
Why?
| | Middle Aged | 3 | 2018 | 35968 | 0.020 |
Why?
| | Hydrocephalus | 1 | 1994 | 111 | 0.020 |
Why?
| | Blood Specimen Collection | 1 | 2012 | 37 | 0.020 |
Why?
| | Esters | 1 | 2012 | 72 | 0.020 |
Why?
| | Animals | 4 | 2020 | 37948 | 0.020 |
Why?
| | Adrenal Cortex Diseases | 1 | 1991 | 1 | 0.020 |
Why?
| | Oxyphil Cells | 1 | 2010 | 1 | 0.020 |
Why?
| | Cysts | 1 | 1991 | 112 | 0.020 |
Why?
| | Chromatography, High Pressure Liquid | 1 | 2012 | 580 | 0.020 |
Why?
| | Thyroidectomy | 1 | 2010 | 91 | 0.020 |
Why?
| | Rats, Sprague-Dawley | 1 | 1995 | 2521 | 0.020 |
Why?
| | Severity of Illness Index | 3 | 2005 | 2922 | 0.020 |
Why?
| | Tandem Mass Spectrometry | 1 | 2012 | 565 | 0.020 |
Why?
| | Incidence | 1 | 1996 | 2892 | 0.020 |
Why?
| | Oxidation-Reduction | 1 | 2012 | 1078 | 0.020 |
Why?
| | Decision Making | 1 | 2014 | 973 | 0.020 |
Why?
| | Rats | 1 | 1995 | 5570 | 0.020 |
Why?
| | Economics, Medical | 1 | 2005 | 6 | 0.010 |
Why?
| | Hospital Departments | 1 | 2005 | 9 | 0.010 |
Why?
| | Laboratories, Hospital | 1 | 2005 | 13 | 0.010 |
Why?
| | Comorbidity | 1 | 2010 | 1652 | 0.010 |
Why?
| | Polymorphism, Genetic | 2 | 2000 | 613 | 0.010 |
Why?
| | Health Maintenance Organizations | 1 | 2005 | 105 | 0.010 |
Why?
| | Costs and Cost Analysis | 1 | 2005 | 221 | 0.010 |
Why?
| | Hospital Costs | 1 | 2005 | 125 | 0.010 |
Why?
| | Specialization | 1 | 2005 | 136 | 0.010 |
Why?
| | Health Resources | 1 | 2005 | 130 | 0.010 |
Why?
| | Radionuclide Imaging | 1 | 2003 | 115 | 0.010 |
Why?
| | Health Expenditures | 1 | 2005 | 194 | 0.010 |
Why?
| | Hydrogen | 1 | 2003 | 75 | 0.010 |
Why?
| | Mice | 1 | 2020 | 18261 | 0.010 |
Why?
| | Needs Assessment | 1 | 2005 | 401 | 0.010 |
Why?
| | Quality of Life | 1 | 2014 | 3183 | 0.010 |
Why?
| | Echocardiography | 1 | 2005 | 644 | 0.010 |
Why?
| | Outpatients | 1 | 2005 | 447 | 0.010 |
Why?
| | Hospitals, Pediatric | 1 | 2005 | 557 | 0.010 |
Why?
| | Cardiac Catheterization | 1 | 2005 | 557 | 0.010 |
Why?
| | Retrospective Studies | 2 | 2003 | 17147 | 0.010 |
Why?
| | Medicaid | 1 | 2005 | 464 | 0.010 |
Why?
| | Inpatients | 1 | 2005 | 547 | 0.010 |
Why?
| | Polymorphism, Restriction Fragment Length | 1 | 2000 | 63 | 0.010 |
Why?
| | Polydactyly | 1 | 1999 | 11 | 0.010 |
Why?
| | Cytogenetic Analysis | 1 | 1999 | 33 | 0.010 |
Why?
| | Karyotyping | 1 | 1999 | 105 | 0.010 |
Why?
| | DNA Mutational Analysis | 1 | 2000 | 409 | 0.010 |
Why?
| | Nuclear Family | 1 | 1999 | 50 | 0.010 |
Why?
| | Magnetic Resonance Imaging | 2 | 2003 | 3887 | 0.010 |
Why?
| | Gas Chromatography-Mass Spectrometry | 1 | 1998 | 127 | 0.010 |
Why?
| | In Situ Hybridization, Fluorescence | 1 | 1999 | 323 | 0.010 |
Why?
| | Ribs | 1 | 1997 | 35 | 0.010 |
Why?
| | Models, Genetic | 1 | 2000 | 531 | 0.010 |
Why?
| | Arm | 1 | 1997 | 110 | 0.010 |
Why?
| | Reference Values | 1 | 1998 | 794 | 0.010 |
Why?
| | Spine | 1 | 1997 | 182 | 0.010 |
Why?
| | Leg | 1 | 1997 | 240 | 0.010 |
Why?
| | Clinical Protocols | 1 | 1997 | 282 | 0.010 |
Why?
| | Translocation, Genetic | 1 | 1995 | 118 | 0.010 |
Why?
| | Pregnancy Outcome | 1 | 1998 | 479 | 0.010 |
Why?
| | Colorado | 1 | 2005 | 4558 | 0.010 |
Why?
| | Gestational Age | 1 | 1998 | 980 | 0.010 |
Why?
| | Hospitalization | 1 | 2005 | 2446 | 0.010 |
Why?
| | Tomography, X-Ray Computed | 1 | 2005 | 2753 | 0.010 |
Why?
| | Cohort Studies | 1 | 2005 | 5957 | 0.010 |
Why?
| | Ursodeoxycholic Acid | 1 | 1994 | 17 | 0.010 |
Why?
| | Ultrasonography | 1 | 1998 | 776 | 0.010 |
Why?
| | Genes, Recessive | 1 | 1994 | 78 | 0.010 |
Why?
| | Failure to Thrive | 1 | 1994 | 28 | 0.010 |
Why?
| | Drug Therapy, Combination | 1 | 1997 | 1044 | 0.010 |
Why?
| | Polymerase Chain Reaction | 1 | 1996 | 1047 | 0.010 |
Why?
| | Fetal Growth Retardation | 1 | 1998 | 591 | 0.010 |
Why?
| | Hypertrophy | 1 | 1991 | 128 | 0.010 |
Why?
| | Feces | 1 | 1994 | 513 | 0.000 |
Why?
| | Prenatal Diagnosis | 1 | 1991 | 196 | 0.000 |
Why?
| | Ultrasonography, Prenatal | 1 | 1991 | 293 | 0.000 |
Why?
| | Liver | 1 | 1997 | 1889 | 0.000 |
Why?
| | Erythrocytes | 1 | 1994 | 750 | 0.000 |
Why?
| | Disease Models, Animal | 1 | 1997 | 4539 | 0.000 |
Why?
|
|
Elias's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|